Sun Dali, Zhao Zhen, Spiegel Sarah, Liu Yang, Fan Jia, Amrollahi Pouya, Hu Jing, Lyon Christopher J, Wan Meihua, Hu Tony Y
Department of Electrical and Computer Engineering, North Dakota State University, 1411 Centennial Blvd., 101M, Fargo, ND, 58102, USA.
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.
Biosens Bioelectron. 2021 May 1;179:113058. doi: 10.1016/j.bios.2021.113058. Epub 2021 Feb 9.
Extracellular vesicles (EVs) can represent a novel source of disease biomarkers, and are under intensive study for their clinical potential. Most EV-based cancer diagnostic studies have focused on establishing EV assays that detect increased expression of a single cancer-associated marker or marker signatures based on multiplex detection of these biomarkers. EV biomarker readouts can be obscured by high background signal leading to false positives, and may markedly differ between analyses due to variation in sample purity during EV isolation. This can obstruct the comparisons among studies and lead to conflicting conclusions. This work reports that the nucleic acid to protein UV absorption ratio of an EV is a cell-specific EV characteristic. This EV collective attribute can be measured at low-cost to discriminate EVs derived from malignant and non-malignant cells rather than employing single markers that may be cancer- or subtype-specific. Our work also highlighted the application for accessing purity in EV preparations irrelevant to EV yield. It can be employed to distinguish from patients with and without malignant disease upon analysis of EVs isolated from their serum samples.
细胞外囊泡(EVs)可能是疾病生物标志物的一种新来源,并且因其临床潜力正在进行深入研究。大多数基于EVs的癌症诊断研究都集中在建立能够检测单一癌症相关标志物表达增加的EV检测方法,或者基于这些生物标志物的多重检测的标志物特征。EV生物标志物的读数可能会被高背景信号掩盖,导致假阳性,并且由于EV分离过程中样品纯度的变化,不同分析之间可能会有显著差异。这可能会阻碍研究之间的比较,并导致相互矛盾的结论。这项工作报告称,EV的核酸与蛋白质紫外吸收比是一种细胞特异性的EV特征。这种EV的共同属性可以低成本测量,以区分源自恶性和非恶性细胞的EVs,而不是使用可能是癌症特异性或亚型特异性的单一标志物。我们的工作还强调了该方法在评估与EV产量无关的EV制剂纯度方面的应用。在分析从患者血清样本中分离出的EVs时,它可用于区分患有和未患有恶性疾病的患者。